Medinice S.A. (WSE: ICE)

Poland flag Poland · Delayed Price · Currency is PLN
7.60
-0.25 (-3.18%)
Jan 20, 2025, 1:02 PM CET
-23.69%
Market Cap 49.63M
Revenue (ttm) 218.00K
Net Income (ttm) -4.39M
Shares Out 6.46M
EPS (ttm) -0.68
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 9,664
Average Volume 13,180
Open 7.88
Previous Close 7.85
Day's Range 7.55 - 7.88
52-Week Range 7.00 - 13.50
Beta 1.19
RSI 43.20
Earnings Date Apr 1, 2025

About Medinice

Medinice S.A. focuses on creating, developing, and commercializing medical technologies for cardiology and cardio surgery. The company provides advisory services in the field of commercialization of research and development products; and undertakes preclinical tests, clinical trials, and obtaining a certificate for sale of medical technology. Medinice S.A. was incorporated in 2012 and is headquartered in Warsaw, Poland. [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2012
Employees 16
Stock Exchange Warsaw Stock Exchange
Ticker Symbol ICE
Full Company Profile

Financial Performance

In 2023, Medinice's revenue was 225,000, a decrease of -8.54% compared to the previous year's 246,000. Losses were -5.07 million, 2.98% more than in 2022.

Financial Statements

News

There is no news available yet.